Literature DB >> 10364378

Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function.

Y Cui1, T Iwakuma, L J Chang.   

Abstract

The mobile transgene constructs of most human immunodeficiency virus (HIV)-based lentivirus vectors currently in use contain viral long terminal repeats, a 5' untranslated region, gag sequences, and env sequences that include the Rev-responsive element (RRE). In this study, we examined the possibility of deleting HIV splice sites and gag and env sequences from an HIV type 1 recombinant vector established in our laboratory as part of our ongoing efforts to improve this vector system. Mutations in the major splice donor site (SD) markedly reduced viral RNA expression but had little effect on vector titer. Deletion of gag or env sequences, excluding RRE, led to a moderate reduction in vector titer. Interestingly, deletion of RRE slightly reduced viral RNA expression but markedly impaired vector function. Combined deletions of RRE, gag (except for the first 40 nucleotides), env, and the SD mutation resulted in a twofold increase in cytoplasmic viral RNA expression and a recovery of vector efficiency to approximately 50% of the wild-type level. This increase in cytoplasmic RNA levels is likely to be due, at least in part, to effects of the TE671 host cells, a human rhabdomyosarcoma cell line used for vector production in our system, on the cytoplasmic distribution of spliced and unspliced viral RNA. These results show that optimal lentivirus vector function can be maintained in the absence of multiple essential viral elements.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364378      PMCID: PMC112687     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.

Authors:  L J Chang; V Urlacher; T Iwakuma; Y Cui; J Zucali
Journal:  Gene Ther       Date:  1999-05       Impact factor: 5.250

2.  The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region.

Authors:  S K Barksdale; C C Baker
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

3.  Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.

Authors:  G Nasioulas; A S Zolotukhin; C Tabernero; L Solomin; C P Cunningham; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

4.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron.

Authors:  M L Hammarskjöld; H Li; D Rekosh; S Prasad
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.

Authors:  C Parolin; T Dorfman; G Palú; H Göttlinger; J Sodroski
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals.

Authors:  D W Brighty; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

9.  Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome.

Authors:  H S Olsen; A W Cochrane; C Rosen
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

10.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

Authors:  J Clever; C Sassetti; T G Parslow
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more
  20 in total

1.  A Fourth Generation Lentiviral Vector: Simplifying Genomic Gymnastics.

Authors:  Ben Berkhout
Journal:  Mol Ther       Date:  2017-08-02       Impact factor: 11.454

2.  Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism.

Authors:  Ren-Jye Lin; Bi-Lan Chang; Han-Pang Yu; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 3.  Biosafety features of lentiviral vectors.

Authors:  Axel Schambach; Daniela Zychlinski; Birgitta Ehrnstroem; Christopher Baum
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

4.  A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.

Authors:  Matthew S Dahabieh; Marcel Ooms; Viviana Simon; Ivan Sadowski
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

5.  A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.

Authors:  E Kotsopoulou; V N Kim; A J Kingsman; S M Kingsman; K A Mitrophanous
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Induction of primary anti-HIV CD4 and CD8 T cell responses by dendritic cells transduced with self-inactivating lentiviral vectors.

Authors:  Xiaochuan Chen; Bei Wang; Lung-Ji Chang
Journal:  Cell Immunol       Date:  2006-12-22       Impact factor: 4.868

7.  The cellular antiviral protein viperin is attenuated by proteasome-mediated protein degradation in Japanese encephalitis virus-infected cells.

Authors:  Yi-Lin Chan; Tsung-Hsien Chang; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

8.  RNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy.

Authors:  Anne-Kathrin Zaiss; Sodany Son; Lung-Ji Chang
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection.

Authors:  Leor S Weinberger; David V Schaffer; Adam P Arkin
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair.

Authors:  Rachel M Koldej; Donald S Anson
Journal:  BMC Biotechnol       Date:  2009-10-07       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.